Novo Nordisk A/S ADR (NY: NVO )

105.50 +0.44 (+0.42%)
Streaming Delayed Price Updated: 9:50 AM EST, Nov 25, 2024 Add to My Watchlist

Other Filings

Form IRANNOTICE
Source: SEC/Edgar
February 07, 2018
Form S-8
Source: SEC/Edgar
February 07, 2018
Form 6-K
Source: SEC/Edgar
February 07, 2018
Form 20-F
Source: SEC/Edgar
February 07, 2018
Form 6-K
Source: SEC/Edgar
February 06, 2018
Form 6-K
Source: SEC/Edgar
February 05, 2018
Form 6-K
Source: SEC/Edgar
February 05, 2018
Form 6-K
Source: SEC/Edgar
February 04, 2018
Form 6-K
Source: SEC/Edgar
February 01, 2018
Form SC 13G
Source: SEC/Edgar
January 31, 2018
Form 6-K
Source: SEC/Edgar
January 30, 2018
Form 6-K
Source: SEC/Edgar
January 22, 2018
Form 6-K
Source: SEC/Edgar
January 07, 2018
Form 6-K
Source: SEC/Edgar
January 01, 2018
Form 6-K
Source: SEC/Edgar
January 01, 2018
Form 6-K
Source: SEC/Edgar
December 26, 2017
Form 6-K
Source: SEC/Edgar
December 14, 2017
Form 6-K
Source: SEC/Edgar
December 11, 2017
Form 6-K
Source: SEC/Edgar
December 07, 2017
Form 6-K
Source: SEC/Edgar
December 03, 2017
Form 6-K
Source: SEC/Edgar
November 27, 2017
Form 6-K
Source: SEC/Edgar
November 20, 2017
Form 6-K
Source: SEC/Edgar
November 20, 2017
Form 6-K
Source: SEC/Edgar
November 12, 2017
Form 6-K
Source: SEC/Edgar
November 05, 2017
Form 6-K
Source: SEC/Edgar
October 30, 2017
Form S-8
Source: SEC/Edgar
October 30, 2017
Form 6-K
Source: SEC/Edgar
October 22, 2017
Form 6-K
Source: SEC/Edgar
October 18, 2017
Form 6-K
Source: SEC/Edgar
October 09, 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.